Gregory J. Flesher
2018 - Tokai Pharmaceuticals
In 2018, Gregory J. Flesher earned a total compensation of $943.1K as Chief Executive Officer at Tokai Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $191,194 |
|---|---|
| Option Awards | $191,327 |
| Salary | $459,865 |
| Stock Awards | $99,255 |
| Other | $1,440 |
| Total | $943,081 |
Flesher received $459.9K in salary, accounting for 49% of the total pay in 2018.
Flesher also received $191.2K in non-equity incentive plan, $191.3K in option awards, $99.3K in stock awards and $1.4K in other compensation.
Rankings
In 2018, Gregory J. Flesher's compensation ranked 9,479th out of 14,244 executives tracked by ExecPay. In other words, Flesher earned more than 33.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,479 out of 14,244 | 34th |
Division Manufacturing | 3,809 out of 5,765 | 34th |
Major group Chemicals And Allied Products | 1,435 out of 2,128 | 33rd |
Industry group Drugs | 1,210 out of 1,817 | 33rd |
Industry Pharmaceutical Preparations | 934 out of 1,391 | 33rd |
Source: SEC filing on May 15, 2019.
Flesher's colleagues
We found two more compensation records of executives who worked with Gregory J. Flesher at Tokai Pharmaceuticals in 2018.
News
Reneo Pharmaceuticals CEO Gregory Flesher's 2022 pay falls 78% to $1.2M
April 26, 2023
Reneo Pharmaceuticals CEO Gregory Flesher's 2021 pay jumps 3,939% to $5.4M
April 22, 2022
Tokai Pharmaceuticals CEO Gregory Flesher's 2019 pay slips 11% to $843K
March 31, 2020
Tokai Pharmaceuticals CEO Gregory Flesher's 2018 pay slips 2% to $943K
May 15, 2019